Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

AbbVie patents new Nampt inhibitors

June 5, 2013

AstraZeneca to return rights to RA candidate following phase III results

June 5, 2013

GlaxoSmithKline to develop and commercialize MOR-103

June 5, 2013

Researchers at Eli Lilly disclose novel retinoid RAR-gamma receptor antagonists

May 31, 2013

Chugai launches Actemra subcutaneous injection in Japan

May 24, 2013

Identification of a DMOAD candidate for osteoarthritis treatment

May 24, 2013

Two new trials under way in sarilumab phase III program

May 16, 2013

Chinese group presents new DHODH inhibitors

May 14, 2013

Novartis obtains FDA approval for Ilaris in active systemic juvenile idiopathic arthritis

May 13, 2013

New androgen receptor modulators patented by Eli Lilly

May 13, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...